Patent ID: 7776853

Claim:
A method for the treatment of obesity or an obesity-related disorder selected from the group consisting of hyperlipaemia, hyperlipidaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disease, stroke, gastrointestinal disease, and gastrointestinal conditions, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula (II): or a pharmaceutically acceptable salt, ester, amide or prodrug thereof, wherein: R 1 is a branched or unbranched alkyl or phenyl wherein said phenyl group can be substituted with one or more substituents independently chosen from the group consisting of halogen, alkyl, halosubstituted alkyl, —CO 2 R 4 , and —OR 6 ; R 2 is hydrogen; and where: R 4 is alkyl; R 6 is alkyl or phenyl; and R 8 , R 9 , R 10 , and R 11 are each independently hydrogen, halo, alkyl, or haloalkyl.